Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Chinese Journal of Radiation Oncology ; (6): 35-40, 2017.
Article in Chinese | WPRIM | ID: wpr-509162

ABSTRACT

Objective To analyze the prognosis of advanced esophageal carcinoma treated with paclitaxel and different platinum?based chemotherapy regimens plus intensity?modulated radiotherapy ( IMRT) , and to explore an optimal chemotherapy regimen. Methods A total of 242 patients with advanced esophageal carcinoma who were admitted to our hospital and treated with paclitaxel and cisplatin ( 68 patients), nedaplatin (85 patients), lobaplatin (58 patients), or oxaliplatin (31 patients) plus IMRT from 2008 to 2014 were enrolled as subjects. The prognosis of the four groups was analyzed after 2, 3, and ≥4 cycles of chemotherapy. The survival rates were calculated by the Kaplan?Meier method and analyzed by the log?rank test. The Cox model was used for the multivariate prognostic analysis. Results The sample number of 3 years was 168 cases. In all the 242 patients, the medium survival time was 31. 1 months and the 3?year overall survival ( OS) rate was 47. 4%. There was no significant difference in the 3?year OS rate between the cispaltin, nedaplatin, lobaplatin, and oxaliplatin groups ( 46. 2% vs. 56. 4% vs. 45. 7% vs. 29. 0%, P=0. 090) . The stratified analysis showed that the cisplatin, nedaplatin, and lobaplatin groups had a significantly higher OS rate than the oxaliplatin group ( 50. 1% vs. 29. 0%, P=0. 021 ) . There was no significant difference in the 3?year OS rate between patients receiving 2, 3, and≥4 cycles of chemotherapy ( 40. 1% vs. 49. 5% vs. 50. 8%, P=0. 264) . The multivariate analysis showed that esophageal tumor volume and the maximal size of metastatic lymph node were independent prognostic factors. Conclusions Combined with IMRT, paclitaxel plus cisplatin, nedaplatin, or lobaplatin?based chemotherapy achieves improved survival rates than paclitaxel plus oxaliplatin?based chemotherapy. Esophageal tumor volume and the maximal size of metastatic lymph node are independent prognostic factors.

2.
Chinese Journal of Microsurgery ; (6)2000.
Article in Chinese | WPRIM | ID: wpr-675522

ABSTRACT

Objective To prove the extracellular ATP attracts the axonal regeneration after peripheral nerve injury via the ATP receptor Methods The sciatic nerve defects had been made in 10 female Sprague Danley rats and repaired by"Y" form silicon tube The single arm of the"Y" form tube were sutured with the proxma the sciatic nerve and the other two end of silicon tube sutured by paralled or cross method so as to differentiate the experimental side and control side, 1mmol/L 10 ?l ATP and 1mmol/L 10 ?m ATP+ 0 2mg/ml Suramin were injected differently into two arms of left side and 10 ?l physiological saling and 10 ?l 0 2mg/ml Suramin injected differently into two arms of right dide The silicon tube were removed after eight weeks and examine the form and number of myelinated tibers as well as the quanlity of the myelinated sheath Results In the left sides regeneration axon were tuned into the silicon tubes containing the ATP and there were not axon regeneration in the silicon tube contained the ATP and there were not axon regeneration in the silicon tube contained ATP+ Suramin In the right sides the regeneration axon were found only three tubes contained suramin and seven tubes contained physiological saline Conclusions The results demonstrated that the suramin inhibited the axon reduction of the extracellular ATP completely

SELECTION OF CITATIONS
SEARCH DETAIL